路创丽医疗器械（上海）有限公司

Lutronic, an exclusively foreign-owned enterprise, was established in South Korea in 1997 and relocated its headquarters to Boston, USA in 2017, positioning itself as a global company. The firm dedicates substantial resources annually, allocating 20% of its earnings to research and development. Currently, it boasts over 500 global patents and more than 300 published clinical papers. With a global workforce exceeding 250 personnel, Lutronic maintains offices in the USA, South Korea, China, Japan, and Germany. Its products and services are distributed worldwide through a network of dealers.

Since its inception, Lutronic has supplied its services and products to over 60 countries globally. It offers a wide range of treatments, encompassing but not limited to the treatment of hyperpigmentation (such as melasma), tattoo removal, soft tissue excision, vascular lesions, hair removal, anti-aging, body contouring/facial sculpting, and management of chronic pain.